A multi-billion-pound market with a position no one occupies
Growing at 5–7% per year through 2030
The global mosquito control market is driven by public health mandates, NGO procurement, and rising consumer demand for non-toxic alternatives. Sub-Saharan Africa, South Asia, and Southeast Asia represent the highest-volume opportunity — with the UK and Europe as accessible near-term launch markets.
No existing product addresses individual-level adaptive acoustic repulsion. ISARS enters a proven, large market with a demonstrably superior approach to a problem that current solutions have failed to fully solve.
Six routes to revenue
Households — Endemic Regions
Phase 1NGO supply & direct distribution
UK & European Consumer
Phase 1E-commerce & retail partnerships
Healthcare Facilities
Phase 2B2B bulk supply to clinics & hospitals
Travel & Tourism
Phase 2Premium retail tier for travellers
Public Health Programmes
Phase 3Government & donor procurement
Technology Licensing
Phase 3OEM & platform integration
Multiple paths to revenue
Device Sales
Consumer and retail sales at a target price of £70 per device through e-commerce and distribution partners worldwide.
Institutional Supply
Bulk supply agreements with healthcare organisations, NGOs, and government health ministries at volume pricing.
Software & Data Services
Subscription tier for over-the-air model updates as the dataset expands. Aggregated population-level data has value to epidemiologists.
Technology Licensing
Licensing of the acoustic identification and adaptive response methodology to OEM manufacturers and IoT platform providers.